Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)

FOSTER CITY, Calif., Nov. 28, 2023 -- Apollomics Inc. , a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and...

Related Keywords

China ,Illinois ,United States ,Kunpeng ,Guangdong ,Chicago ,Sean Leous ,Peter Vozzo ,Nasdaq ,Exchange Commission ,Securities Exchange ,Avistone Biotechnology Co ,Apollomics Inc ,National Medical Products Administration ,America Conference ,Lung Cancer ,Without Concurrent ,Distributions Compared With Public ,Avistone Biotechnology ,Securities Act ,Securities Exchange Act ,Markets ,